ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flow Cytometry in Oncology and Immunology Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-32E14374
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Flow Cytometry in Oncology and Immunology Market Research Report 2023
BUY CHAPTERS

Global Flow Cytometry in Oncology and Immunology Market Research Report 2025

Code: QYRE-Auto-32E14374
Report
April 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agilent
Bio Rad Laboratories
Cell Signaling Technology
Cytek Biosciences
Danaher Corporation
Laboratory Corporation of America Holdings
Merck KGaA
Miltenyi Biotec
Neogenomics Laboratories
OPKO Health
Sony Group Corporation
Thermo Fisher Scientific Inc
ABYNTEK BIOPHARMA
DiaSorin S.p.A (Luminex Corporation),
Enzi Biochem Inc

Flow Cytometry in Oncology and Immunology Market

The global market for Flow Cytometry in Oncology and Immunology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Flow cytometry is a powerful technology that is widely used in both oncology and immunology research. It is a technique used to analyze the physical and chemical properties of cells in a heterogeneous population, by labeling and detecting specific molecules on the surface of cells. The resulting data can provide information about the number, size, and complexity of cells in a sample, as well as their phenotype and function.
In oncology, flow cytometry is often used to analyze cancer cells and to monitor the progression of the disease. For example, flow cytometry can be used to identify and quantify cancer stem cells, which are thought to be responsible for tumor initiation and recurrence. It can also be used to measure the expression of tumor-associated antigens, which are molecules expressed by cancer cells that can be targeted by immunotherapy.
Overall, flow cytometry is a versatile tool that has many applications in oncology and immunology research. It can provide valuable information about the biology of cells and their interactions with other cells and molecules, and can help researchers to develop new diagnostic and therapeutic approaches for cancer and other diseases
The global increase in HIV diagnoses is a significant market factor for flow cytometry, and this is because the flow cytometry technique is specifically used for HIV diagnosis. In flow cytometry, light scattering is utilized to identify cells. These cells receive particular markers known as CDs depending on the type of scattering (clusters of differentiation). The main market players are concentrating on creating new products, which is anticipated to propel market growth over the forecast year.
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry in Oncology and Immunology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry in Oncology and Immunology.
The Flow Cytometry in Oncology and Immunology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flow Cytometry in Oncology and Immunology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flow Cytometry in Oncology and Immunology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Flow Cytometry in Oncology and Immunology Market Report

Report Metric Details
Report Name Flow Cytometry in Oncology and Immunology Market
Segment by Type
  • Products
  • Services
Segment by Application
  • Immunology
  • Oncology
  • Solid Tumor
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent, ABYNTEK BIOPHARMA, Bio-Rad Laboratories, Cell Signaling Technology, Cytek Biosciences, Danaher Corporation,, DiaSorin S.p.A (Luminex Corporation),, Enzi Biochem Inc, Laboratory Corporation of America Holdings,, Merck KGaA, Miltenyi Biotec, NeoGenomics Laboratories, OPKO Health, Sony Group Corporation, Thermo Fisher Scientific Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Flow Cytometry in Oncology and Immunology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Flow Cytometry in Oncology and Immunology Market report?

Ans: The main players in the Flow Cytometry in Oncology and Immunology Market are Agilent, ABYNTEK BIOPHARMA, Bio-Rad Laboratories, Cell Signaling Technology, Cytek Biosciences, Danaher Corporation,, DiaSorin S.p.A (Luminex Corporation),, Enzi Biochem Inc, Laboratory Corporation of America Holdings,, Merck KGaA, Miltenyi Biotec, NeoGenomics Laboratories, OPKO Health, Sony Group Corporation, Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Flow Cytometry in Oncology and Immunology Market report?

Ans: The Applications covered in the Flow Cytometry in Oncology and Immunology Market report are Immunology, Oncology, Solid Tumor

What are the Type segmentation covered in the Flow Cytometry in Oncology and Immunology Market report?

Ans: The Types covered in the Flow Cytometry in Oncology and Immunology Market report are Products, Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Products
1.2.3 Services
1.3 Market by Application
1.3.1 Global Flow Cytometry in Oncology and Immunology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunology
1.3.3 Oncology
1.3.4 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry in Oncology and Immunology Market Perspective (2020-2031)
2.2 Global Flow Cytometry in Oncology and Immunology Growth Trends by Region
2.2.1 Global Flow Cytometry in Oncology and Immunology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Flow Cytometry in Oncology and Immunology Historic Market Size by Region (2020-2025)
2.2.3 Flow Cytometry in Oncology and Immunology Forecasted Market Size by Region (2026-2031)
2.3 Flow Cytometry in Oncology and Immunology Market Dynamics
2.3.1 Flow Cytometry in Oncology and Immunology Industry Trends
2.3.2 Flow Cytometry in Oncology and Immunology Market Drivers
2.3.3 Flow Cytometry in Oncology and Immunology Market Challenges
2.3.4 Flow Cytometry in Oncology and Immunology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue
3.1.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue (2020-2025)
3.1.2 Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Players (2020-2025)
3.2 Global Flow Cytometry in Oncology and Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Flow Cytometry in Oncology and Immunology Revenue
3.4 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio
3.4.1 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology and Immunology Revenue in 2024
3.5 Global Key Players of Flow Cytometry in Oncology and Immunology Head office and Area Served
3.6 Global Key Players of Flow Cytometry in Oncology and Immunology, Product and Application
3.7 Global Key Players of Flow Cytometry in Oncology and Immunology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry in Oncology and Immunology Breakdown Data by Type
4.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Type (2020-2025)
4.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Type (2026-2031)
5 Flow Cytometry in Oncology and Immunology Breakdown Data by Application
5.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Application (2020-2025)
5.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Flow Cytometry in Oncology and Immunology Market Size (2020-2031)
6.2 North America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)
6.4 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry in Oncology and Immunology Market Size (2020-2031)
7.2 Europe Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)
7.4 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size (2020-2031)
8.2 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2020-2025)
8.4 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry in Oncology and Immunology Market Size (2020-2031)
9.2 Latin America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)
9.4 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size (2020-2031)
10.2 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025)
10.4 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Details
11.1.2 Agilent Business Overview
11.1.3 Agilent Flow Cytometry in Oncology and Immunology Introduction
11.1.4 Agilent Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.1.5 Agilent Recent Development
11.2 ABYNTEK BIOPHARMA
11.2.1 ABYNTEK BIOPHARMA Company Details
11.2.2 ABYNTEK BIOPHARMA Business Overview
11.2.3 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Introduction
11.2.4 ABYNTEK BIOPHARMA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.2.5 ABYNTEK BIOPHARMA Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Introduction
11.3.4 Bio-Rad Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Details
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Introduction
11.4.4 Cell Signaling Technology Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.4.5 Cell Signaling Technology Recent Development
11.5 Cytek Biosciences
11.5.1 Cytek Biosciences Company Details
11.5.2 Cytek Biosciences Business Overview
11.5.3 Cytek Biosciences Flow Cytometry in Oncology and Immunology Introduction
11.5.4 Cytek Biosciences Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.5.5 Cytek Biosciences Recent Development
11.6 Danaher Corporation,
11.6.1 Danaher Corporation, Company Details
11.6.2 Danaher Corporation, Business Overview
11.6.3 Danaher Corporation, Flow Cytometry in Oncology and Immunology Introduction
11.6.4 Danaher Corporation, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.6.5 Danaher Corporation, Recent Development
11.7 DiaSorin S.p.A (Luminex Corporation),
11.7.1 DiaSorin S.p.A (Luminex Corporation), Company Details
11.7.2 DiaSorin S.p.A (Luminex Corporation), Business Overview
11.7.3 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Introduction
11.7.4 DiaSorin S.p.A (Luminex Corporation), Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.7.5 DiaSorin S.p.A (Luminex Corporation), Recent Development
11.8 Enzi Biochem Inc
11.8.1 Enzi Biochem Inc Company Details
11.8.2 Enzi Biochem Inc Business Overview
11.8.3 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Introduction
11.8.4 Enzi Biochem Inc Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.8.5 Enzi Biochem Inc Recent Development
11.9 Laboratory Corporation of America Holdings,
11.9.1 Laboratory Corporation of America Holdings, Company Details
11.9.2 Laboratory Corporation of America Holdings, Business Overview
11.9.3 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Introduction
11.9.4 Laboratory Corporation of America Holdings, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.9.5 Laboratory Corporation of America Holdings, Recent Development
11.10 Merck KGaA
11.10.1 Merck KGaA Company Details
11.10.2 Merck KGaA Business Overview
11.10.3 Merck KGaA Flow Cytometry in Oncology and Immunology Introduction
11.10.4 Merck KGaA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.10.5 Merck KGaA Recent Development
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Details
11.11.2 Miltenyi Biotec Business Overview
11.11.3 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Introduction
11.11.4 Miltenyi Biotec Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.11.5 Miltenyi Biotec Recent Development
11.12 NeoGenomics Laboratories
11.12.1 NeoGenomics Laboratories Company Details
11.12.2 NeoGenomics Laboratories Business Overview
11.12.3 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Introduction
11.12.4 NeoGenomics Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.12.5 NeoGenomics Laboratories Recent Development
11.13 OPKO Health
11.13.1 OPKO Health Company Details
11.13.2 OPKO Health Business Overview
11.13.3 OPKO Health Flow Cytometry in Oncology and Immunology Introduction
11.13.4 OPKO Health Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.13.5 OPKO Health Recent Development
11.14 Sony Group Corporation
11.14.1 Sony Group Corporation Company Details
11.14.2 Sony Group Corporation Business Overview
11.14.3 Sony Group Corporation Flow Cytometry in Oncology and Immunology Introduction
11.14.4 Sony Group Corporation Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.14.5 Sony Group Corporation Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Details
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Agilent
Bio Rad Laboratories
Cell Signaling Technology
Cytek Biosciences
Danaher Corporation
Laboratory Corporation of America Holdings
Merck KGaA
Miltenyi Biotec
Neogenomics Laboratories
OPKO Health
Sony Group Corporation
Thermo Fisher Scientific Inc
ABYNTEK BIOPHARMA
DiaSorin S.p.A (Luminex Corporation),
Enzi Biochem Inc
List of Tables
 Table 1. Global Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Products
 Table 3. Key Players of Services
 Table 4. Global Flow Cytometry in Oncology and Immunology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Flow Cytometry in Oncology and Immunology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Flow Cytometry in Oncology and Immunology Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Flow Cytometry in Oncology and Immunology Market Share by Region (2020-2025)
 Table 8. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Flow Cytometry in Oncology and Immunology Market Share by Region (2026-2031)
 Table 10. Flow Cytometry in Oncology and Immunology Market Trends
 Table 11. Flow Cytometry in Oncology and Immunology Market Drivers
 Table 12. Flow Cytometry in Oncology and Immunology Market Challenges
 Table 13. Flow Cytometry in Oncology and Immunology Market Restraints
 Table 14. Global Flow Cytometry in Oncology and Immunology Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Flow Cytometry in Oncology and Immunology Market Share by Players (2020-2025)
 Table 16. Global Top Flow Cytometry in Oncology and Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology and Immunology as of 2024)
 Table 17. Ranking of Global Top Flow Cytometry in Oncology and Immunology Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Flow Cytometry in Oncology and Immunology Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Flow Cytometry in Oncology and Immunology, Headquarters and Area Served
 Table 20. Global Key Players of Flow Cytometry in Oncology and Immunology, Product and Application
 Table 21. Global Key Players of Flow Cytometry in Oncology and Immunology, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Flow Cytometry in Oncology and Immunology Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Type (2020-2025)
 Table 25. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Type (2026-2031)
 Table 27. Global Flow Cytometry in Oncology and Immunology Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Application (2020-2025)
 Table 29. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Application (2026-2031)
 Table 31. North America Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Agilent Company Details
 Table 47. Agilent Business Overview
 Table 48. Agilent Flow Cytometry in Oncology and Immunology Product
 Table 49. Agilent Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 50. Agilent Recent Development
 Table 51. ABYNTEK BIOPHARMA Company Details
 Table 52. ABYNTEK BIOPHARMA Business Overview
 Table 53. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product
 Table 54. ABYNTEK BIOPHARMA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 55. ABYNTEK BIOPHARMA Recent Development
 Table 56. Bio-Rad Laboratories Company Details
 Table 57. Bio-Rad Laboratories Business Overview
 Table 58. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product
 Table 59. Bio-Rad Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 60. Bio-Rad Laboratories Recent Development
 Table 61. Cell Signaling Technology Company Details
 Table 62. Cell Signaling Technology Business Overview
 Table 63. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product
 Table 64. Cell Signaling Technology Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 65. Cell Signaling Technology Recent Development
 Table 66. Cytek Biosciences Company Details
 Table 67. Cytek Biosciences Business Overview
 Table 68. Cytek Biosciences Flow Cytometry in Oncology and Immunology Product
 Table 69. Cytek Biosciences Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 70. Cytek Biosciences Recent Development
 Table 71. Danaher Corporation, Company Details
 Table 72. Danaher Corporation, Business Overview
 Table 73. Danaher Corporation, Flow Cytometry in Oncology and Immunology Product
 Table 74. Danaher Corporation, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 75. Danaher Corporation, Recent Development
 Table 76. DiaSorin S.p.A (Luminex Corporation), Company Details
 Table 77. DiaSorin S.p.A (Luminex Corporation), Business Overview
 Table 78. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product
 Table 79. DiaSorin S.p.A (Luminex Corporation), Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 80. DiaSorin S.p.A (Luminex Corporation), Recent Development
 Table 81. Enzi Biochem Inc Company Details
 Table 82. Enzi Biochem Inc Business Overview
 Table 83. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product
 Table 84. Enzi Biochem Inc Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 85. Enzi Biochem Inc Recent Development
 Table 86. Laboratory Corporation of America Holdings, Company Details
 Table 87. Laboratory Corporation of America Holdings, Business Overview
 Table 88. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product
 Table 89. Laboratory Corporation of America Holdings, Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 90. Laboratory Corporation of America Holdings, Recent Development
 Table 91. Merck KGaA Company Details
 Table 92. Merck KGaA Business Overview
 Table 93. Merck KGaA Flow Cytometry in Oncology and Immunology Product
 Table 94. Merck KGaA Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 95. Merck KGaA Recent Development
 Table 96. Miltenyi Biotec Company Details
 Table 97. Miltenyi Biotec Business Overview
 Table 98. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product
 Table 99. Miltenyi Biotec Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 100. Miltenyi Biotec Recent Development
 Table 101. NeoGenomics Laboratories Company Details
 Table 102. NeoGenomics Laboratories Business Overview
 Table 103. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product
 Table 104. NeoGenomics Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 105. NeoGenomics Laboratories Recent Development
 Table 106. OPKO Health Company Details
 Table 107. OPKO Health Business Overview
 Table 108. OPKO Health Flow Cytometry in Oncology and Immunology Product
 Table 109. OPKO Health Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 110. OPKO Health Recent Development
 Table 111. Sony Group Corporation Company Details
 Table 112. Sony Group Corporation Business Overview
 Table 113. Sony Group Corporation Flow Cytometry in Oncology and Immunology Product
 Table 114. Sony Group Corporation Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 115. Sony Group Corporation Recent Development
 Table 116. Thermo Fisher Scientific Inc. Company Details
 Table 117. Thermo Fisher Scientific Inc. Business Overview
 Table 118. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product
 Table 119. Thermo Fisher Scientific Inc. Revenue in Flow Cytometry in Oncology and Immunology Business (2020-2025) & (US$ Million)
 Table 120. Thermo Fisher Scientific Inc. Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Flow Cytometry in Oncology and Immunology Picture
 Figure 2. Global Flow Cytometry in Oncology and Immunology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Flow Cytometry in Oncology and Immunology Market Share by Type: 2024 VS 2031
 Figure 4. Products Features
 Figure 5. Services Features
 Figure 6. Global Flow Cytometry in Oncology and Immunology Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Flow Cytometry in Oncology and Immunology Market Share by Application: 2024 VS 2031
 Figure 8. Immunology Case Studies
 Figure 9. Oncology Case Studies
 Figure 10. Solid Tumor Case Studies
 Figure 11. Flow Cytometry in Oncology and Immunology Report Years Considered
 Figure 12. Global Flow Cytometry in Oncology and Immunology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Flow Cytometry in Oncology and Immunology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Flow Cytometry in Oncology and Immunology Market Share by Region: 2024 VS 2031
 Figure 15. Global Flow Cytometry in Oncology and Immunology Market Share by Players in 2024
 Figure 16. Global Top Flow Cytometry in Oncology and Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology and Immunology as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology and Immunology Revenue in 2024
 Figure 18. North America Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)
 Figure 20. United States Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)
 Figure 24. Germany Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Share by Region (2020-2031)
 Figure 32. China Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)
 Figure 40. Mexico Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Share by Country (2020-2031)
 Figure 44. Turkey Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Agilent Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 48. ABYNTEK BIOPHARMA Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 50. Cell Signaling Technology Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 51. Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 52. Danaher Corporation, Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 53. DiaSorin S.p.A (Luminex Corporation), Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 54. Enzi Biochem Inc Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 55. Laboratory Corporation of America Holdings, Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 56. Merck KGaA Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 57. Miltenyi Biotec Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 58. NeoGenomics Laboratories Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 59. OPKO Health Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 60. Sony Group Corporation Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 61. Thermo Fisher Scientific Inc. Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Flow Cytometry Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Flow Cytometry in Oncology Market Research Report 2024
Infrared Flow Cytometry Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Flow Detection Service Market Research Report 2024
Research Flow Cytometry Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Flow Cytometric Market Research Report 2024
Global Flow Cytometry Solutions Market Research Report 2025
Global Flow Cytometry Service Market Research Report 2024
Global Fluorescence Activated Cell Sorting Market Research Report 2024
Flow Cytometry System Market
Laser Flow Cytometers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Flow Cytometer Market Research Report 2025
Flow Cytometry Testing Technology Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Flow Cytometry Product Market Research Report 2024
Global Analytical Flow Cytometry Market Research Report 2024
Automatic Flow Cytometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Desktop Cytometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ultra high speed Sorting Flow Cytometer Market Research Report 2024
Benchtop Flow Cytometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Speed Flow Cytometry Sorter Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions